Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A responseMarius Piepke, Mathias Gelderblom, Yasushi Kobayashi et al.|Journal of Neuroinflammation|2021Cited by 66
A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic strokeMathias Gelderblom, Tim Magnus, Jan‐Kolja Strecker et al.|Brain Communications|2023Cited by 12
Neuroglial P2Y1 receptor signalling differentially contributes to inflammatory neurodegenerationCharlotte Schubert, Manuel A. Friese, Ricardo Lopes Fonseca et al.|Journal of Neuroinflammation|2026Cited by 0
Additional file 1 of Neuroglial P2Y1 receptor signalling differentially contributes to inflammatory neurodegenerationCharlotte Schubert, Manuel A. Friese, Ricardo Lopes Fonseca et al.|Figshare|2026Cited by 0
Additional file 1 of Neuroglial P2Y1 receptor signalling differentially contributes to inflammatory neurodegenerationCharlotte Schubert, Manuel A. Friese, Ricardo Lopes Fonseca et al.|Figshare|2026Cited by 0